Formulary Search
A to Z of Drugs : O
Records returned : 75 (on 29 May 2025 at 00:07:59).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Dose adjustment and monitoring in pre-existing moderate / severe hepatic impairment.
NHSE specialised commissioning - RSFT only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
ASPH are the only Surrey Heartlands Trust commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Depot injection
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
NHSE Specialist Centres - only commissioned from RSFT in Surrey Heartlands.
SASH - only for use under shared care arrangements with specialist centres.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prevention of complications following pancreatic surgery
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
ASPH are the only Surrey Heartlands Trust commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
- Tablets
Restrictions / Comments:
Important
Off-label use. On recommendation of palliative care team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
- Tablets
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Off-label use. Primary care prescribing on request of specialist palliative care team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use. Primary care prescribing on request of specialist palliative care team.
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Available to purchase for self care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Soft mist inhaler
Restrictions / Comments:
Important
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Prescribe generically.
Sodium cromoglycate 2% or Antazoline with Xylometazoline (Otrivine-Antistin) are the preferred antihistamine/anti-inflammatory eye drops
Olopatidine licensed from 3 years of age.
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Licensed in mild ulcerative colitis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Service not currently provided by any Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Prescribing in Primary Care may continue for existing patients under certain circumstances whilst waiting for specialist review. Please see PAD for detail
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
1st line for patients with no swallowing difficulties.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Omeprazole or lansoprazole capsules are 1st-line.
Pantoprazole or rabeprazole tablets are 2nd-line for patients without swallowing difficulties (suitable for patients that cannot have animal-derived products).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Oro-dispersible
Restrictions / Comments:
Important
Omeprazole capsules can be opened for patients with swallowing difficulties.
Lansoprazole oro-dispersible tablets are 1st-line for patients with enteral feeding tubes
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
1st line option in children who are able to swallow capsules.
Most capsules can also be opened and mixed with water or fruit juice (licensed).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Dispersible tablets
Restrictions / Comments:
Important
Mezzopram is the preferred brand - smaller granule size. Omeprazole MUPS is an alternative.
Disperse in water then mix with juice, apple sauce or yoghurt
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
Only for children under 10kg and/or with a feeding tube less than 8Fr
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Powder
Restrictions / Comments:
Important
Aclomep powder - ASPH NICU only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ASPH use pantoprazole IV 1st-line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ASPH use pantoprazole IV 1st-line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ASPH use pantoprazole IV 1st-line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Oral solution
- Tablets
Restrictions / Comments:
Important
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Off-label use. Only licensed for post-operative and chemotherapy-induced nausea and vomiting
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
- Orodispersible films
Restrictions / Comments:
Important
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Oral solution reserved for use when tablets are not suitable.
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
- Orodispersible films
Restrictions / Comments:
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Oral solution
- Oro-dispersible
- Tablets
Restrictions / Comments:
Important
Off-label use. On recommendation of palliative care team
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Oral solution
- Tablets
Restrictions / Comments:
Important
Oral solution reserved for use when tablets are not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
- Orodispersible films
Restrictions / Comments:
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suppositories
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Orodispersible films
Restrictions / Comments:
Important
An option in patients with swallowing difficulties.
2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oro-dispersible
Restrictions / Comments:
Important
Orodispersible films are a more cost effective option than oral solution and orodispersible tablets.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
2nd line COMT inhibitor.
Entacapone is the locally agreed 1st-line choice
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Severe dry eye
Prescribe by brand. Prescribe on specialist initiation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oromucosal gel
Restrictions / Comments:
Important
Oncology request only. Primary Care prescribing may be appropriate in longer-term use and on request from oncology specialist team only.
Ongoing use should be reviewed regularly to ensure that therapy is still required.
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
This device has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to APC.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
- Tablets
Restrictions / Comments:
Important
recommended for treatment of influenza in adults and children meeting the criteria set out in NICE TA 168 and for prophylaxis of influenza in adults and children meeting the criteria set out in NICE TA 158
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation in primary care following specialist recommendation. Reserve for severe dryness or when other treatments are ineffective / contraindicated.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.4% preservative free eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Capsules (slow release)
- Tablets
- Tablets (slow release)
Restrictions / Comments:
Important
On recommendation from specialist team. Modified release may be used for patients with intolerable side effects to IR formulation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Elixir
- Liquid
- Oral solution
- Oral suspension
- Patches
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Important
Solifenacin 1mg/ml oral SUSPENSION is preferred for patients with swallowing difficulties.
Oxybutynin patches are reserved for patients where an oral formulation is not suitable
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Oral solution
- Tablets
Restrictions / Comments:
Important
Switch to solifenacin recommended (if appropriate).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravesical
Restrictions / Comments:
Important
This drug has not yet been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an application to the APC.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
For use in patients where morphine sulfate is not suitable / not tolerated.
Modified-release preparations to be prescribed by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
For patients unable to tolerate / poor response to morphine. Modified-release preparations to be prescribed by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Alternative for patients unable to tolerate / poor response to morphine.
Care with dose conversion.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
For patients unable to tolerate / poor response to morphine.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
For use in patients where morphine sulfate is not suitable / not tolerated.
Modified-release preparations to be prescribed by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Ulcerative Colitis - adults only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :